Samsung Bioepis Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) have announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for OPUVIZ™ 40 mg/mL solution for injection in a vial,…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) have received a recommendation for marketing authorization from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for their Omicron KP.2-adapted monovalent COVID-19 vaccine (COMIRNATY®…
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions recommending the approval of KEYTRUDA® (pembrolizumab) for two gynecologic cancer indications.…
The Family Heart Foundation, a prominent research and advocacy organization, has announced the successful completion of its Flag, Identify, Network, and Deliver™ “FIND Lp(a)” machine learning model. This groundbreaking tool is now being implemented in healthcare systems across the United…
Organon (NYSE: OGN), a global healthcare company dedicated to improving women’s health, has announced a definitive agreement to acquire Dermavant Sciences, a subsidiary of Roivant (NASDAQ: ROIV). Dermavant specializes in developing innovative therapies for immuno-dermatology. The acquisition includes VTAMA® (tapinarof)…
Wedgewood Pharmacy has officially added molnupiravir to its formulary, offering a new option for the treatment of Feline Infectious Peritonitis (FIP). Originally developed to treat viral infections in humans, including COVID-19, molnupiravir is now recognized as a promising therapeutic option…
Blue Cross and Blue Shield of Alabama is dedicated to ensuring its members receive high-quality, affordable care through cost-effective healthcare providers. Starting December 1, 2024, Labcorp, a leader in comprehensive laboratory services, will be the exclusive national laboratory for Blue…
Zoetis Inc., the leading global animal health company, is set to launch its new Vetscan OptiCell™ hematology analyzer, a cutting-edge diagnostic tool that combines cartridge-based technology with AI-powered capabilities for advanced Complete Blood Count (CBC) analysis. Expected to debut in…
Massive Bio Launches Patient Connect: A Revolutionary Platform for Global Cancer Clinical Trial Access Massive Bio, a global frontrunner in AI-driven cancer clinical trial enrollment, has unveiled Patient Connect, a groundbreaking and free portal designed to guide cancer patients through…
Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, has announced new findings from a study using its Cellworks Platform to predict homologous recombination deficiency (HRD) and the effectiveness of PARP inhibitors (PARPi) across real-world…
Novotech, a global contract research organization (CRO), has announced the appointment of Dr. Yooni Kim as Executive President of Asia Pacific (APAC), effective September 1, 2024. This move reflects Novotech’s dedication to expanding its global reach and enhancing its operational…
Results from the DESTINY-Breast12 Phase IIIb/IV trial reveal that Enhertu (trastuzumab deruxtecan) demonstrated significant overall and intracranial clinical activity in patients with HER2-positive metastatic breast cancer, including those with brain metastases who had undergone no more than two previous lines…